featured
Lipid-Lowering Effects of Obicetrapib in Combination With High-Intensity Statins
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Nature Medicine
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Lipid lowering effects of the CETP inhibitor obicetrapib in combination with high-intensity statins: a randomized phase 2 trial
Nat. Med. 2022 Aug 11;[EPub Ahead of Print], SJ Nicholls, M Ditmarsch, JJ Kastelein, SP Rigby, D Kling, DL Curcio, NJ Alp, MH DavidsonFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.